# Edgewell Personal Care share price today (Edgewell Personal Care Company, EPC)

> Edgewell Personal Care Company's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. EPC · Consumer Staples · Household & Personal Products · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/epc

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $27.93 (+44.0% in a year)
- Revenue (Jun 2026): $570 M
- Profit (Jun 2026): $13.7 M
- Operating margin: 8.8%
- ROE: 2%, FY25
- ROIC: 7.3%, against a 5.2% cost of capital: +2.1 points

The main question: the share price moved +44.0% in a year while yearly earnings per share moved −73.1%. The difference came from the market paying a higher multiple. ## What is the Edgewell Personal Care share price today? Edgewell Personal Care Company's share price was $27.93 at the close on 3 November 2026. That is 16.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $16 and $30, and at that close it sat 87% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 2 weeks in a row. Over the last 1 year the share price moved +3% while the S&P 500 moved +21%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Edgewell Personal Care pay? Edgewell Personal Care Company paid $0.60 per share over the last four reported quarters. The most recent declaration was $0.15 for Jun 2026. At today's price of $27.93 that is a yield of 2.15%, based on dividends already paid, not a forecast. ## Which stock lists is Edgewell Personal Care on? Edgewell Personal Care is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Edgewell Personal Care profitable? Edgewell Personal Care Company earned $13.7 M of net profit in the Jun 2026 quarter. Full-year FY25 profit was $25.4 M. Over 4 years profit has grown −31.9% a year on average. That is 2.4% of the quarter's revenue. The same quarter a year earlier earned $49.0 M. 2 of the last 8 reported quarters were loss-making. For the full year, FY25 profit was $25.4 M (−74.2% on the year before). ## How much revenue does Edgewell Personal Care make, and is it growing? Edgewell Personal Care Company reported $570 M of revenue in the Jun 2026 quarter. Over 4 years it has grown 1.6% a year on average. The last full year, FY25, came in at $2.2 B. The quarterly figures for FY25 do not add up to the full-year total on file, so those quarters are left out of the charts and sums. FY25 revenue was $2.2 B, −1.3% on the year before. ## How much of every $100 of sales does Edgewell Personal Care keep? Edgewell Personal Care Company's operating margin was 8.8% in the Jun 2026 quarter. Across 5 years it has been between 9.3% and 13.5%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −5.2 percentage points on the year while gross margin changed −0.2 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Edgewell Personal Care's profit turning into cash? Over the last 3 years, 237% of Edgewell Personal Care Company's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $118 M of operating cash against $25.4 M of profit. After $77.0 M of spending on assets, $41.4 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Edgewell Personal Care's cash go? Edgewell Personal Care Company does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $183 M on assets over the last 3 years. Averaged over those years that is 2.7% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $183 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Edgewell Personal Care's P/E ratio, and how does it compare with its own history? Edgewell Personal Care Company has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Edgewell Personal Care Company at 0.6× its FY25 revenue of $2.2 B. The P/E comes back here once profit turns positive. Why the multiple is where it is: over the past year earnings per share moved −73.1% while the price moved +44.0%. The price did better than earnings, which pushed the multiple up within its own range. ## Is the Edgewell Personal Care business getting better or worse? Edgewell Personal Care Company's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 5 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Edgewell Personal Care earn on its capital? Edgewell Personal Care Company earned a ROE of 2% in FY25. Its return on capital used (ROIC) is 2.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 1.1% net margin and 0.59× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 1.1% net margin × 0.59× asset turnover × 2.42× leverage (assets divided by equity) ≈ 1.6% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 7.3% − 5.2% = +2.1 percentage points. The 5.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. ## Does Edgewell Personal Care have too much debt? Edgewell Personal Care Company has total debt of $1.3 B against shareholder equity of $1.5 B as of Jun 2026, so its debt is 0.88× its equity. Year by year, that ratio went from 0.83 in FY21 to 0.96 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Edgewell Personal Care shareholding pattern? 11.2% of Edgewell Personal Care Company's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 8.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Edgewell Personal Care from balance-sheet trouble? For Edgewell Personal Care Company, the Z-score is 1.65. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 1.65 is inside the danger zone, so the balance sheet is a real risk. ## How does Edgewell Personal Care rank in its industry? 41.6 out of 100, rank 14 of 20 in Household & Personal Products, with 71% of the evidence available. Edgewell Personal Care Company scores 41.6 out of 100 against the 20 companies it is compared with in Household & Personal Products, ranking 14. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 10.7 + 7.1 + 11.2 + 12.6 = 41.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Edgewell Personal Care compared with? Edgewell Personal Care ranks 14 of 20 Household & Personal Products companies on the 4-Factor Sector Score, with 41.6 out of 100. 1. [Kenvue Inc.](https://www.sectoralpha.in/us/stocks/kvue) KVUE · Evidence leans up · 61% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.7/43.75 · Revenue 1.8% · Profit 16.9% · Operating margin change -0.4 points · 83% evidence Capital efficiency 21.1/31.25 · ROCE 14.4% · Operating margin 19.4% · 76% evidence Valuation 15.1/25 · P/E 22.2× · PEG 1.37 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 27.7 + 21.1 + 15.1 = 63.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 2. [Church & Dwight Co., Inc.](https://www.sectoralpha.in/us/stocks/chd) CHD · turning · Evidence leans up · 81% evidence 61.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.6/35 · Revenue 2.7% · Profit 41.9% · Operating margin change -2.7 points · 83% evidence Capital efficiency 15.8/25 · ROCE 14.6% · Operating margin 18.1% · 76% evidence Valuation 14.3/20 · P/E 30.8× · PEG 0.66 · 65% evidence Relative strength 13.1/20 · Lead over its industry 1.3% · Lead over S&P 500 8.7% · 1 year 25.7% · 100% evidence · 2 of 12 weeks ahead Exact sum: 18.6 + 15.8 + 14.3 + 13.1 = 61.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [The Estée Lauder Companies Inc.](https://www.sectoralpha.in/us/stocks/el) EL · leader · Evidence leans up · 64% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 5% · Profit n/a · Operating margin change 2.7 points · 62% evidence Capital efficiency 11.0/25 · ROCE 12.3% · Operating margin 7% · 76% evidence Valuation 11.5/20 · P/E -104.7× · PEG n/a · 15% evidence Relative strength 13.2/20 · Lead over its industry 0% · Lead over S&P 500 6.7% · 1 year 20.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.7 + 11 + 11.5 + 13.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Procter & Gamble Company](https://www.sectoralpha.in/us/stocks/pg) PG · turning · Evidence leans up · 85% evidence 58.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.7/35 · Revenue 3.5% · Profit -4.4% · Operating margin change 0.3 points · 95% evidence Capital efficiency 21.2/25 · ROCE 24.6% · Operating margin 27.1% · 76% evidence Valuation 6.7/20 · P/E 21.4× · PEG 2.4 · 65% evidence Relative strength 10.5/20 · Lead over its industry -3.3% · Lead over S&P 500 3.7% · 1 year 10.3% · 100% evidence · 3 of 12 weeks ahead Exact sum: 19.7 + 21.2 + 6.7 + 10.5 = 58.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 5. [Colgate-Palmolive Company](https://www.sectoralpha.in/us/stocks/cl) CL · turning · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Revenue 5.2% · Profit -29.2% · Operating margin change 0.1 points · 83% evidence Capital efficiency 21.1/25 · ROCE 40.8% · Operating margin 21% · 76% evidence Valuation 7.7/20 · P/E 36× · PEG 2.18 · 65% evidence Relative strength 8.1/20 · Lead over its industry -3.6% · Lead over S&P 500 3.4% · 1 year 21.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.2 + 21.1 + 7.7 + 8.1 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Acme United Corporation](https://www.sectoralpha.in/us/stocks/acu) ACU · leader · Evidence leans up · 81% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Revenue 9.3% · Profit -9.1% · Operating margin change -0.9 points · 83% evidence Capital efficiency 10.9/25 · ROCE 8.7% · Operating margin 10.9% · 76% evidence Valuation 6.7/20 · P/E 18.5× · PEG 2.5 · 65% evidence Relative strength 19.1/20 · Lead over its industry 28% · Lead over S&P 500 36.8% · 1 year 88.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 16.8 + 10.9 + 6.7 + 19.1 = 53.5 · What this means: Relative strength against the index is 36.8%, and revenue and profit growth are weak. 7. [Interparfums, Inc.](https://www.sectoralpha.in/us/stocks/ipar) IPAR · quiet · Evidence leans up · 81% evidence 52.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 2.9% · Profit 4.4% · Operating margin change -5.4 points · 83% evidence Capital efficiency 17.9/25 · ROCE 21% · Operating margin 12.3% · 76% evidence Valuation 9.7/20 · P/E 21.4× · PEG 1.99 · 65% evidence Relative strength 10.9/20 · Lead over its industry 3% · Lead over S&P 500 10.3% · 1 year 34% · 100% evidence · 5 of 12 weeks ahead Exact sum: 13.9 + 17.9 + 9.7 + 10.9 = 52.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Kimberly-Clark Corporation](https://www.sectoralpha.in/us/stocks/kmb) KMB · basing · Evidence leans up · 81% evidence 50.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue 0.7% · Profit -18.9% · Operating margin change 2.8 points · 83% evidence Capital efficiency 20.6/25 · ROCE 24.6% · Operating margin 19% · 76% evidence Valuation 7.6/20 · P/E 18.6× · PEG 2.38 · 65% evidence Relative strength 5.2/20 · Lead over its industry -10% · Lead over S&P 500 -3.6% · 1 year 0.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.1 + 20.6 + 7.6 + 5.2 = 50.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Newell Brands Inc.](https://www.sectoralpha.in/us/stocks/nwl) NWL · losing its lead · Evidence leans up · 64% evidence 50.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue -2% · Profit n/a · Operating margin change 5.2 points · 62% evidence Capital efficiency 8.6/25 · ROCE 7.3% · Operating margin 14.7% · 76% evidence Valuation 11.0/20 · P/E -11.8× · PEG n/a · 15% evidence Relative strength 11.4/20 · Lead over its industry 8.6% · Lead over S&P 500 16% · 1 year 77.6% · 100% evidence · 7 of 12 weeks ahead Exact sum: 19.3 + 8.6 + 11 + 11.4 = 50.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Helen of Troy Limited](https://www.sectoralpha.in/us/stocks/hele) HELE · turning · Evidence leans down · 67% evidence 49.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.8/35 · Revenue 0.3% · Profit n/a · Operating margin change -2.6 points · 71% evidence Capital efficiency 9.4/25 · ROCE 9.8% · Operating margin 0.5% · 76% evidence Valuation 10.7/20 · P/E -7.1× · PEG n/a · 15% evidence Relative strength 14.3/20 · Lead over its industry 13.8% · Lead over S&P 500 22.2% · 1 year 52.3% · 100% evidence · 2 of 12 weeks ahead Exact sum: 14.8 + 9.4 + 10.7 + 14.3 = 49.2 · What this means: Relative strength against the index is 22.2%, and revenue and profit growth are weak. 11. [e.l.f. Beauty, Inc.](https://www.sectoralpha.in/us/stocks/elf) ELF · leader · Evidence leans down · 81% evidence 48.7 out of 100 Growth Capital Valuation Relative
12. [Spectrum Brands Holdings, Inc.](https://www.sectoralpha.in/us/stocks/spb) SPB · quiet · Evidence leans down · 81% evidence 45.1 out of 100 Growth Capital Valuation Relative
13. [Coty Inc.](https://www.sectoralpha.in/us/stocks/coty) COTY · breaking out · Evidence leans down · 64% evidence 44.3 out of 100 Growth Capital Valuation Relative
14. Edgewell Personal Care Company this page EPC · turning · Evidence leans down · 71% evidence 41.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.7/35 · Revenue 2% · Profit -244.6% · Operating margin change -2.3 points · 83% evidence Capital efficiency 7.1/25 · ROCE 4.9% · Operating margin 8.8% · 76% evidence Valuation 11.2/20 · P/E -13.3× · PEG n/a · 15% evidence Relative strength 12.6/20 · Lead over its industry 9.2% · Lead over S&P 500 16.7% · 1 year 49.1% · 100% evidence · 5 of 12 weeks ahead Exact sum: 10.7 + 7.1 + 11.2 + 12.6 = 41.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 15. [Magnera Corporation](https://www.sectoralpha.in/us/stocks/magn) MAGN · quiet · Evidence leans down · 64% evidence 39.4 out of 100 Growth Capital Valuation Relative
16. [The Clorox Company](https://www.sectoralpha.in/us/stocks/clx) CLX · basing · Evidence leans down · 81% evidence 38.4 out of 100 Growth Capital Valuation Relative
17. [The Honest Company, Inc.](https://www.sectoralpha.in/us/stocks/hnst) HNST · losing its lead · Evidence leans down · 71% evidence 35.0 out of 100 Growth Capital Valuation Relative
18. [Nu Skin Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/nus) NUS · basing · Most evidence points down · 71% evidence 30.6 out of 100 Growth Capital Valuation Relative
19. [Oddity Tech Ltd.](https://www.sectoralpha.in/us/stocks/odd) ODD · breaking out · Most evidence points down · 81% evidence 24.7 out of 100 Growth Capital Valuation Relative
20. [Unilever PLC](https://www.sectoralpha.in/us/stocks/ul) UL · turning · Too little evidence to rank firmly · 47% evidence 50.1 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Household & Personal Products](https://www.sectoralpha.in/us/sectors/household-personal-products), all 20 compared on one page. ## Which companies are close to Edgewell Personal Care in size? Edgewell Personal Care is the 14th largest of 22 Household & Personal Products companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Coty Inc., Newell Brands Inc. and Spectrum Brands Holdings, Inc. Just below it: Oddity Tech, Helen of Troy and The Honest Company, Inc. ### Household & Personal Products companies close in size

1. [Coty Inc.](https://www.sectoralpha.in/us/stocks/coty) $2.9 billion
2. [Newell Brands Inc.](https://www.sectoralpha.in/us/stocks/nwl) $2.4 billion
3. [Spectrum Brands Holdings, Inc.](https://www.sectoralpha.in/us/stocks/spb) $2 billion
4. Edgewell Personal Care Company $1.3 billion
5. [Oddity Tech Ltd.](https://www.sectoralpha.in/us/stocks/odd) $925 million
6. [Helen of Troy Limited](https://www.sectoralpha.in/us/stocks/hele) $691 million
7. [The Honest Company, Inc.](https://www.sectoralpha.in/us/stocks/hnst) $467 million

[All 22 Household & Personal Products companies, largest first](https://www.sectoralpha.in/us/sectors/household-personal-products#all-companies)

### Companies close in size in other industries

1. [Capital Clean Energy Carriers Corp.](https://www.sectoralpha.in/us/stocks/ccec) $1.3 billion · Marine Shipping
2. [AEVEX Corp.](https://www.sectoralpha.in/us/stocks/avex) $1.3 billion · Aerospace & Defense
3. Edgewell Personal Care Company $1.3 billion
4. [Grocery Outlet Holding Corp.](https://www.sectoralpha.in/us/stocks/go) $1.3 billion · Grocery Stores
5. [The Greenbrier Companies, Inc.](https://www.sectoralpha.in/us/stocks/gbx) $1.3 billion · Railroads

## What else do people ask about Edgewell Personal Care? ### What were Edgewell Personal Care's latest quarterly results? Edgewell Personal Care Company reported revenue of $570 M and net profit of $13.7 M for the Jun 2026 quarter. Earnings per share were $0.29. The operating margin was 8.8% (as of 3 November 2026). ### What is Edgewell Personal Care's market cap? Edgewell Personal Care Company's market capitalisation is $1.3 B at a stock price of $27.93. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Edgewell Personal Care performing? Edgewell Personal Care Company's latest readings are below. Over the past 13 weeks it has done better than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Edgewell Personal Care's stock price go up? This page does not forecast Edgewell Personal Care Company's stock price. What it shows instead: the stock price is $27.93. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Edgewell Personal Care in its business cycle? Edgewell Personal Care Company's FY25 operating margin was 9.3%, against a 5-year range of 9.3% to 13.5%: the low end of its own range, which is often where recoveries start. The latest quarter was 8.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Edgewell Personal Care story? The main question: the share price moved +44.0% in a year while yearly earnings per share moved −73.1%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Edgewell Personal Care a stock worth studying right now? What the numbers show: Edgewell Personal Care Company's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.